Decentralized Trials
Decentralized Trials
Care Access is a leading decentralized research organization (DRO) that breaks down traditional barriers in clinical research for patients, sponsors, and physicians. Its innovative model brings decentralized trials, Sites On Demand™, Virtual Principal Investigators (PIs), and Mobile Sites to previously-unreachable patient populations to expand the impact of clinical research. Supported by top pharmaceutical and biotech partners across 20 different therapeutic areas, Care Access is scaling and globalizing its new model for clinical trial delivery, where more physicians and patients can engage in life-saving research to develop new therapies faster.
"Before new medications are made available to the public, they must undergo a rigorous scientific testing process. Only the few that can continue to accumulate evidence of their safety and efficacy throughout the entire process, which starts in the laboratory and proceeds up through clinical trials with patient volunteers, are allowed to continue on the path to FDA approval. Care Access is working to make this process better, faster and more efficient."
See also: Science 37
Castor is a leading provider of clinical trial technology that automates the research process. Castor is helping Democratize Clinical Research and making DCT scalable with EDC, eConsent, ePRO & eCOA + DCT integrations. These solutions enable researchers to easily capture and integrate data from any source and decentralize their trials.
Medable's mission is to get effective therapies to patients faster. They provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Their solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Remote positions are locations-specific.
Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, they provide access to patients who can never be reached by traditional site-based models. They have proven to enroll faster, retain patients at a higher rate, and reach a more representative population. Science 37 has conducted more decentralized, interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses, who are supported by the industry’s most comprehensive, fully integrated, decentralized clinical trial platform. Most remote positions are location-specific.
